Rosen Law Firm Launches Investigation on Semler Scientific, Inc. Securities Claims Amid Concerns Over Accuracy of Business Information

Overview of Semler Scientific Securities Investigation



On June 17, 2025, Rosen Law Firm, an esteemed global investor rights law firm, announced the commencement of an investigation into Semler Scientific, Inc. (NASDAQ: SMLR). This inquiry focuses on potential securities claims stemming from allegations that the company may have provided misleading business information to its shareholders.

Background of Semler Scientific



Semler Scientific, a prominent firm in the medical device sector, specializes in developing innovative solutions aimed at enhancing cardiovascular healthcare. However, recent events have raised red flags concerning the accuracy of their disclosures and whether investors were fully informed about the risks associated with their investment in the company.

Allegations and Stock Impact



The critical issue emerged after Semler Scientific filed its 2024 annual report on Form 10-K with the SEC following the closing of market hours on February 28, 2025. This filing disclosed a significant matter: discussions between Semler Scientific and the U.S. Department of Justice (DOJ) regarding a potential civil lawsuit concerning allegations of false claims. According to the report, initial discussions had ceased as of February 11, 2025, leading to heightened uncertainty regarding the company's financial liabilities. Following this announcement, Semler Scientific's stock plummeted by over 9% in the subsequent trading session, sparking concern among its investors.

Potential for Recovery through Class Action



For shareholders who have acquired Semler Scientific securities, there is now a possibility of recovering losses through a class action lawsuit. The Rosen Law Firm advocates that investors may be entitled to compensation without incurring any out-of-pocket fees, thanks to a contingency fee arrangement. Those interested in joining the class action are encouraged to visit the firm’s website or reach out directly to discuss their eligibility and the next steps.

Why Choose Rosen Law Firm?



Rosen Law Firm underscores the importance of selecting qualified legal counsel with a proven success record in handling securities class actions. Their firm has established a formidable reputation within the legal community, recognized for significant settlements, including the largest securities class action settlement against a Chinese company at that time. Over the years, they have rapidly gained prominence, consistently ranking among the top firms in securities litigation. In 2019 alone, Rosen Law Firm secured over $438 million for investors and has managed to regain substantial amounts for clients in preceding years. The firm's dedication to investor rights is unwavering, making them a trusted ally for those seeking compensation.

Call to Action for Investors



If you have purchased securities from Semler Scientific, whether during or before the period in question, you are encouraged to reach out to the Rosen Law Firm to understand your options. The team is available to answer inquiries and provide guidance tailored to your unique situation. Don't miss the opportunity to claim your rightful compensation via the ongoing investigation.

Conclusion



In conclusion, as the investigation by Rosen Law Firm unfolds, investors are advised to stay informed and proactive about their rights. Follow the firm on social media platforms for real-time updates regarding the status of the investigation and other relevant news. Investing in your future means remaining vigilant and informed; let the Rosen Law Firm support you in navigating these complex legal waters.

  • ---
For more information, contact:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll-Free: (866) 767-3653
Email: [email protected]
Website: www.rosenlegal.com

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.